J-GLOBAL ID：201901002596775002
Update date: Mar. 15, 2024
YAMAKI KAORI
ヤマキ カオリ | YAMAKI KAORI
Research theme for competitive and other funds (1)：
2015 - 2018 Effective combination of heavy ion beams and anti-VEGF antibody by targeting neural tumor stem cells
Papers (21)：
Ryosuke Matsuda, Masatoshi Hasegawa, Tetsuro Tamamoto, Nobuyoshi Inooka, Takayuki Morimoto, Ryosuke Maeoka, Tsutomu Nakazawa, Tomoko Ochi, Toshiteru Miyasaka, Shigeto Hontsu, et al. Clinical Results and Hematologic Predictors of Linear Accelerator-Based Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy for Brain Metastasis in Patients Aged 75 Years or Older: A Retrospective Study. World Neurosurgery. 2024. 183. e944-e952
Yasushi Nakai, Nobumichi Tanaka, Isao Asakawa, Shunta Hori, Makito Miyake, Kaori Yamaki, Satoshi Anai, Kazumasa Torimoto, Takeshi Inoue, Masatoshi Hasegawa, et al. Quality of life in patients who underwent robot-assisted radical prostatectomy compared with those who underwent low-dose-rate brachytherapy. The Prostate. 2023. 83. 7. 701-712
Nobumichi Tanaka, Yasushi Nakai, Isao Asakawa, Kaori Yamaki, Makito Miyake, Shunta Hori, Takuya Owari, Tomomi Fujii, Kiyohide Fujimoto. Local dose (biologically effective dose ≥180 Gy2) is an important predictor of biochemical recurrence in patients undergoing low-dose-rate brachytherapy. International journal of urology : official journal of the Japanese Urological Association. 2022. 29. 12. 1560-1568
Ryosuke Matsuda, Masatoshi Hasegawa, Tetsuro Tamamoto, Nobuyoshi Inooka, Mei Nikimoto, Tomoko Ochi, Toshiteru Miyasaka, Shigeto Hontsu, Kaori Yamaki, Sachiko Miura, et al. Long-Term Survival after Linac-Based Stereotactic Radiosurgery and Radiotherapy with a Micro-Multileaf Collimator for Brain Metastasis. Current oncology (Toronto, Ont.). 2022. 29. 9. 6068-6076
Yasushi Nakai, Nobumichi Tanaka, Isao Asakawa, Yosuske Morizawa, Kaori Yamaki, Shunta Hori, Daisuke Gotoh, Makito Miyake, Kazumasa Torimoto, Masatoshi Hasegawa, et al. Late genitourinary and gastrointestinal toxicity and radiation-induced second primary cancers in patients treated with low-dose-rate brachytherapy. Brachytherapy. 2022. 21. 5. 626-634
